CN-A- 104 524 546 (B1)

EL-HATTAB AYMAN W ET AL: "Mitochondrial DNA Depletion Syndromes: Review and Updates of Genetic Basis, Manifestations, and Therapeutic Options", NEUROTHERAPEUTICS, ELSEVIER INC, US, vol. 10, no. 2, 6 February 2013 (2013-02-06), pages 186-198, XP035352266, ISSN: 1933-7213, DOI: 10.1007/S13311-013-0177-6 [retrieved on 2013-02-06] (B1)

KEIKO SAITO ET AL: "Pyruvate therapy for mitochondrial DNA depletion syndrome", BIOCHIMICA ET BIOPHYSICA ACTA (BBA) - GENERAL SUBJECTS, vol. 1820, no. 5, 1 May 2012 (2012-05-01), pages 632-636, XP055228134, AMSTERDAM, NL ISSN: 0304-4165, DOI: 10.1016/j.bbagen.2011.08.006 (B1)

RUSSELL P. SANETO ET AL: "Alpers-Huttenlocher Syndrome", PEDIATRIC NEUROLOGY., vol. 48, no. 3, 1 March 2013 (2013-03-01), pages 167-178, XP055228448, NL ISSN: 0887-8994, DOI: 10.1016/j.pediatrneurol.2012.09.014 (B1)

Y. CAMARA ET AL: "Administration of deoxyribonucleosides or inhibition of their catabolism as a pharmacological approach for mitochondrial DNA depletion syndrome", HUMAN MOLECULAR GENETICS, vol. 23, no. 9, 1 May 2014 (2014-05-01), pages 2459-2467, XP055228156, gb ISSN: 0964-6906, DOI: 10.1093/hmg/ddt641 (B1)

S. KRISHNAN ET AL: "Transgene Expression of Drosophila melanogaster Nucleoside Kinase Reverses Mitochondrial Thymidine Kinase 2 Deficiency", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 288, no. 7, 15 February 2013 (2013-02-15), pages 5072-5079, XP055228429, US ISSN: 0021-9258, DOI: 10.1074/jbc.M112.437152 (B1)

WO-A1-00/50043 (B1)

Walker UA, Venhoff N.: "Uridine in the prevention and treatment of NRTI-related mitochondrial toxicity.", pubmed , 2005, XP002751217, Retrieved from the Internet: URL:http://www.ncbi.nlm.nih.gov/pubmed/161 52713 [retrieved on 2015-01-13] (B1)

S. BULST ET AL: "In vitro supplementation with dAMP/dGMP leads to partial restoration of mtDNA levels in mitochondrial depletion syndromes", HUMAN MOLECULAR GENETICS, vol. 18, no. 9, 1 May 2009 (2009-05-01), pages 1590-1599, XP055228477, gb ISSN: 0964-6906, DOI: 10.1093/hmg/ddp074 (B1)